Osimertinib
SHARE
Molecule Summary
| Uses | Non-small cell lung cancer |
| Therapy | Anti-Neoplastic |
| Side Effects | Low white blood cell counts, Low platelet counts, Diarrhoea, Dry skin, Decreased appetite, Stomatitis, Rash, Paronychia, Pruritus (itching on the skin) |
Medicines
available
19k pincodes
Molecule Description
Osimertinib is an anticancer medicine. It is used to treat metastatic non-small cell lung cancer (NSCLC). It is a prescription medicine and must be taken as advised by the doctor.
Uses
- Non-small cell lung cancer
Contraindications
When should one not use Osimertinib
- Allergy to osimertinib or any ingredients of this medicine
- St. John's Wort should not be used together with this medicine
Side effects
Common side effects of this drug are:
- Low white blood cell counts
- Low platelet counts
- Diarrhoea
- Dry skin
- Decreased appetite
- Stomatitis
- Rash
- Paronychia
- Pruritus (itching on the skin)
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
Talk to your doctor if
- You have lung or breathing problems.
- You have heart problems, including a condition called prolonged QTc
- You have problems with your electrolytes, such as sodium, potassium, calcium or magnesium.
- You have a history of eye problems.
- You are pregnant or plan to become pregnant. Osimertinib can harm an unborn baby.
- You are taking any other medications, including prescription and over-the-counter medicines, vitamins, or herbal supplements, especially heart or blood pressure-controlling medicines.
- Inform your doctor right away if you become pregnant during treatment with Osimertinib.
- Females who are able to become pregnant should use effective birth control during treatment with Osimertinib and for 6 weeks after the final dose.
- Males who have female partners that can become pregnant should use effective birth control during treatment with Osimertinib and for 4 months after the final dose.
- Do not breastfeed during treatment and for 2 weeks after your final dose.
- Inform your doctor immediately if you develop a new fever or fever that does not go away, easy bruising or bleeding that will not stop, unusually pale skin, infection, tiredness, or weakness.
Mode of Action
How Does It Work?
Osimertinib is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). It blocks the activity of EGFR, which controls the growth and division of cancer cells.
Dosage
Overdose
In the event of an overdose, report to your doctor immediately.
Missed a Dose
Report to your doctor immediately. Do not take extra doses to compensate for missed doses.
Frequently Asked Questions (FAQs)
Articles
View AllDid you find this helpful?
References:
Explore More at Pharmeasy
Why trust PharmEasy?
# ONE OF INDIA'S MOST TRUSTED HEALTHCARE PLATFORM
CODAvailable
100%Genuine Medicine
30 DAYReturn Policy









